Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
596,345
-
Share change
-
+110,414
-
Total reported value
-
$17,425,950
-
Price per share
-
$28.97
-
Number of holders
-
39
-
Value change
-
+$3,261,854
-
Number of buys
-
14
-
Number of sells
-
18
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q4 2025
As of 31 Dec 2025,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
39 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
596,345 shares.
The largest 10 holders included
NTV Asset Management LLC, SG Americas Securities, LLC, Brookstone Capital Management, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, Perigon Wealth Management, LLC, Global View Capital Management LLC, Lauer Wealth, LLC, Post Resch Tallon Group Inc., Wealthcare Advisory Partners LLC, and DAVENPORT & Co LLC.
This page lists
39
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.